Stay updated with breaking news from Biocon Sdn. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
CANONSBURG (dpa-AFX) - Mylan Pharmaceuticals Inc., affiliated to healthcare company Viatris Inc., is recalling certain Insulin Glargine (Insulin glargine-yfgn) Injection prefilled pens due to the
The rh-Insulin formulations, Insugen-R, Insugen-N and lnsugen-30/70, are manufactured at Biocon Sdn. Bhd.'s Johor facility.
Malaysia's Ministry of Health has awarded a three-year contract to Biocon Sdn Bhd. As part of the deal, the Biocon subsidiary will manufacture and supply its range of insulins to its partner Duopharma Marketing Sdn Bhd (DMktg)
Biocon Biologics’ Insugen awarded a 3-year contract by Ministry of Health, Malaysia
Mylan is voluntarily recalling 1 lot of Semglee (insulin glargine) prefilled pens.